Donor Lymphocyte Infusion (DLI)

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor

A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor

Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS

Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant

Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation

Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients